Search for the latest oncology news by tumour type
AI beats doctors when it comes to diagnosing breast cancer
Breast cancer is one of the most common cancers to affect women. In both the…
Browsing: Tumour Stream
New treatment options for aggressive lymphomas
Combining a new anti-cancer drug targeting Mcl-1 with current cancer therapies could be an effective…
SABCS 2019: Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual breast cancer
Researchers from The University of Texas MD Anderson Cancer Center have identified a standardised protocol…
MINDACT trial data reveal certain women with luminal breast cancer may be undertreated with tamoxifen alone
Among women with hormone receptor (HR)-positive, HER2-negative breast cancer with a high clinical risk (determined…
SABCS 2019: Patient-reported outcomes predict aromatase inhibitor adherence
If you want to predict which breast cancer patients will most likely stop taking aromatase…
SABCS 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type
A large meta-analysis of breast cancer patients showed that residual cancer burden after neoadjuvant chemotherapy…
Extended letrozole therapy improves disease-free survival in postmenopausal women with HR-positive breast cancer
In the updated results from NRG Oncology/NSABP B-42 trial through 10 years of observation, extending…
Updated APHINITY trial data show addition of pertuzumab to trastuzumab plus chemotherapy continues to yield clinical benefit in patients with operable HER2-positive early breast cancer
Data from six-year analysis of the APHINITY trial showed that adding pertuzumab to the previous…
New HER2 antibody-drug conjugate yielded promising clinical responses in breast cancer patients pretreated with T-DM1
The investigational HER2-targeted antibody-drug conjugate [Fam-] trastuzumab deruxtecan (T-DXd) demonstrated durable objective responses in patients…
Circulating tumour DNA may help predict recurrence in patients with early triple-negative breast cancer
The presence of circulating tumour DNA (ctDNA) in early-stage triple-negative breast cancer helped predict the…